Back to company

Eir Diagnostics ApS: Financial statements 2024

CVR: 40339396

Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -13,347 and a net result of DKK -455,658 compared with DKK -507,135 the year before. Equity amounted to DKK 12,439,941. The solvency ratio was 67.3%. The company had 1 employee in the financial year.

Gross Profit
-13,347 kr.
Profit/Loss
-455,658 kr.
Equity
12,439,941 kr.
Total Assets
18,479,548 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--13 t.-456 t.12.4 mio.1
2023-1.1 mio.-507 t.7.6 mio.3
2022-1.7 mio.-594 t.7.6 mio.4
2021-1.2 mio.-469 t.7.4 mio.-
2020-1.5 mio.-369 t.5.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Eir Diagnostics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Danmarks Tekniske Universitet registered as owner of Eir Diagnostics ApSAug 16, 2024

As of August 16, 2024, Danmarks Tekniske Universitet is registered as an owner of Eir Diagnostics ApS with an ownership share of 10%.

KEMPHANSEN HOLDING ApS registered as owner of Eir Diagnostics ApSAug 16, 2024

As of August 16, 2024, KEMPHANSEN HOLDING ApS is registered as an owner of Eir Diagnostics ApS with an ownership share of 5%.

PLASTISENS ApS registered as owner of Eir Diagnostics ApSAug 16, 2024

As of August 16, 2024, PLASTISENS ApS is registered as an owner of Eir Diagnostics ApS with an ownership share of 20%.

Registered as owner of Eir Diagnostics ApSAug 16, 2024

As of August 16, 2024, is registered as an owner of Eir Diagnostics ApS with an ownership share of 5%.

Eir Diagnostics ApS: The 2023 annual report is outJul 15, 2024

Eir Diagnostics ApS has published its annual report for 2023. Gross profit came to DKK 1,060,807, and the net result was DKK -507,135.

Eir Diagnostics ApS appoints new auditorJun 25, 2024

As of June 25, 2024, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eir Diagnostics ApS.

Auditor steps down at Eir Diagnostics ApSJun 25, 2024

As of June 25, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Eir Diagnostics ApS.

Johannes Dapra joins the board of Eir Diagnostics ApSJan 4, 2024

As of January 4, 2024, Johannes Dapra has joined the board of directors of Eir Diagnostics ApS.

Michael Niels Døssing joins the board of Eir Diagnostics ApSJan 4, 2024

As of January 4, 2024, Michael Niels Døssing has joined the board of directors of Eir Diagnostics ApS.

Torsten Freltoft leaves the board of Eir Diagnostics ApSJan 3, 2024

As of January 3, 2024, Torsten Freltoft has left the board of directors of Eir Diagnostics ApS.

About Eir Diagnostics ApS

Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.

Other financial years